Toshiyuki Toko

Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3.

Markus Borner, Charles E. Myers, Oliver Sartor et al. · PubMed · 1995 · 113 citations

Apoptosis, Cell Death, Macromolecular Synthesis +16

TAT-59, a new triphenylethylene derivative with antitumor activity against hormone-dependent tumors

Toshiyuki Toko, Yoshikazu Sugimoto, Ken-Ichi Matsuo et al. · European Journal of Cancer and Clinical Oncology · 1990 · 39 citations

Tumor Biology, Medicinal Chemistry, Antitumor Activity +11

Augmentation of the chemotherapeutic effectiveness of UFT, a combination of tegafur [1-(2-tetrahydrofuryl)-5-fluorouracil] with uracil, by oral l-leucovorin.

Hiroyuki Okabe, Toshiyuki Toko, Hitoshi Saitô et al. · PubMed · 1997 · 23 citations

Pharmaceutical Science, Chemoprevention Strategy, Combined Modality +19

TAC‐101 (4‐[3,5‐bis(trimethylsilyl)benzamido]benzoic acid) Inhibits Spontaneous Mediastinal Lymph Node Metastasis Produced by Orthotopic Implantation of Lewis Lung Carcinoma

Koji Murakami, Takeshi Yamaura, Kazuhito Suda et al. · Japanese Journal of Cancer Research · 1999 · 16 citations · Full text

Chemoprevention Strategy, Immunology, Pathology +18

Comparative pharmacodynamic analysis of TAT-59 and tamoxifen in rats bearing DMBA-induced mammary carcinoma

Toshiyuki Toko, Jiro Shibata, Yoshikazu Sugimoto et al. · Cancer Chemotherapy and Pharmacology · 1995 · 14 citations

Breast Oncology, Oncology, Medicine +12